Clinical Trials Browser

OTHER × monalizumab × Other hematologic neoplasm × Clear all

NCT06892223 2025-03-24

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

Phase 2 Recruiting

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT02921685 2018-09-19

PIRAT

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms